Cargando…

Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency

BACKGROUND AND AIMS: Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is characterized by localized, non-pitting, and transient swelling of submucosal or subcutaneous region. Human fetuin-A is a multifunctional glycoprotein that belongs to the proteinase inhibitor cystatin superfamily...

Descripción completa

Detalles Bibliográficos
Autores principales: Márkus, Bernadett, Veszeli, Nóra, Temesszentandrási, György, Farkas, Henriette, Kalabay, László
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423823/
https://www.ncbi.nlm.nih.gov/pubmed/30885236
http://dx.doi.org/10.1186/s13023-019-0995-7
_version_ 1783404594402951168
author Márkus, Bernadett
Veszeli, Nóra
Temesszentandrási, György
Farkas, Henriette
Kalabay, László
author_facet Márkus, Bernadett
Veszeli, Nóra
Temesszentandrási, György
Farkas, Henriette
Kalabay, László
author_sort Márkus, Bernadett
collection PubMed
description BACKGROUND AND AIMS: Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is characterized by localized, non-pitting, and transient swelling of submucosal or subcutaneous region. Human fetuin-A is a multifunctional glycoprotein that belongs to the proteinase inhibitor cystatin superfamily and has structural similarities to the high molecular weight kininogen. Fetuin-A is also known a negative acute phase reactant with anti-inflammatory characteristics. In this study we aimed to determine serum fetuin-A, C-reactive protein (CRP) and tumor necrosis factor alpha (TNFα) concentrations in patients with C1-INH-HAE during symptom-free period and during attacks and compare them to those of healthy controls. Further we analyzed possible relationship among these parameters as well as D-dimer levels which was known as marker of HAE attacks. PATIENTS AND METHODS: Serum samples of 25 C1-INH-HAE patients (8 men, 17 women, age: 33.1 ± 6.9 years, mean ± SD) were compared to 25 healthy controls (15 men, 10 women, age: 32.5 ± 7.8 years). Serum fetuin-A and TNFα concentrations were determined by ELISA, CRP and D-dimer by turbidimetry. RESULTS: Compared to healthy controls patients with C1-INH-HAE in the symptom-free period had significantly decreased serum fetuin-A 258 μg/ml (224–285) vs. 293 μg/ml (263–329), (median (25–75% percentiles, p = 0.035) and TNFα 2.53 ng/ml (1.70–2.83) vs. 3.47 ng/ml (2.92–4.18, p = 0.0008) concentrations. During HAE attacks fetuin-A levels increased from 258 (224–285) μg/ml to 287 (261–317) μg/ml (p = 0.021). TNFα and CRP levels did not change significantly. We found no significant correlation among fetuin-A CRP, TNFα and D-dimer levels in any of these three groups. CONCLUSIONS: Patients with C1-INH-HAE have decreased serum fetuin-A concentrations during the symptom-free period. Given the anti-inflammatory properties of fetuin-A, the increase of its levels may contribute to the counter-regulation of edema formation during C1-INH-HAE attacks.
format Online
Article
Text
id pubmed-6423823
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64238232019-03-28 Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency Márkus, Bernadett Veszeli, Nóra Temesszentandrási, György Farkas, Henriette Kalabay, László Orphanet J Rare Dis Research BACKGROUND AND AIMS: Hereditary angioedema with C1-inhibitor deficiency (C1-INH-HAE) is characterized by localized, non-pitting, and transient swelling of submucosal or subcutaneous region. Human fetuin-A is a multifunctional glycoprotein that belongs to the proteinase inhibitor cystatin superfamily and has structural similarities to the high molecular weight kininogen. Fetuin-A is also known a negative acute phase reactant with anti-inflammatory characteristics. In this study we aimed to determine serum fetuin-A, C-reactive protein (CRP) and tumor necrosis factor alpha (TNFα) concentrations in patients with C1-INH-HAE during symptom-free period and during attacks and compare them to those of healthy controls. Further we analyzed possible relationship among these parameters as well as D-dimer levels which was known as marker of HAE attacks. PATIENTS AND METHODS: Serum samples of 25 C1-INH-HAE patients (8 men, 17 women, age: 33.1 ± 6.9 years, mean ± SD) were compared to 25 healthy controls (15 men, 10 women, age: 32.5 ± 7.8 years). Serum fetuin-A and TNFα concentrations were determined by ELISA, CRP and D-dimer by turbidimetry. RESULTS: Compared to healthy controls patients with C1-INH-HAE in the symptom-free period had significantly decreased serum fetuin-A 258 μg/ml (224–285) vs. 293 μg/ml (263–329), (median (25–75% percentiles, p = 0.035) and TNFα 2.53 ng/ml (1.70–2.83) vs. 3.47 ng/ml (2.92–4.18, p = 0.0008) concentrations. During HAE attacks fetuin-A levels increased from 258 (224–285) μg/ml to 287 (261–317) μg/ml (p = 0.021). TNFα and CRP levels did not change significantly. We found no significant correlation among fetuin-A CRP, TNFα and D-dimer levels in any of these three groups. CONCLUSIONS: Patients with C1-INH-HAE have decreased serum fetuin-A concentrations during the symptom-free period. Given the anti-inflammatory properties of fetuin-A, the increase of its levels may contribute to the counter-regulation of edema formation during C1-INH-HAE attacks. BioMed Central 2019-03-18 /pmc/articles/PMC6423823/ /pubmed/30885236 http://dx.doi.org/10.1186/s13023-019-0995-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Márkus, Bernadett
Veszeli, Nóra
Temesszentandrási, György
Farkas, Henriette
Kalabay, László
Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
title Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
title_full Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
title_fullStr Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
title_full_unstemmed Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
title_short Serum fetuin-A, tumor necrosis factor alpha and C-reactive protein concentrations in patients with hereditary angioedema with C1-inhibitor deficiency
title_sort serum fetuin-a, tumor necrosis factor alpha and c-reactive protein concentrations in patients with hereditary angioedema with c1-inhibitor deficiency
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423823/
https://www.ncbi.nlm.nih.gov/pubmed/30885236
http://dx.doi.org/10.1186/s13023-019-0995-7
work_keys_str_mv AT markusbernadett serumfetuinatumornecrosisfactoralphaandcreactiveproteinconcentrationsinpatientswithhereditaryangioedemawithc1inhibitordeficiency
AT veszelinora serumfetuinatumornecrosisfactoralphaandcreactiveproteinconcentrationsinpatientswithhereditaryangioedemawithc1inhibitordeficiency
AT temesszentandrasigyorgy serumfetuinatumornecrosisfactoralphaandcreactiveproteinconcentrationsinpatientswithhereditaryangioedemawithc1inhibitordeficiency
AT farkashenriette serumfetuinatumornecrosisfactoralphaandcreactiveproteinconcentrationsinpatientswithhereditaryangioedemawithc1inhibitordeficiency
AT kalabaylaszlo serumfetuinatumornecrosisfactoralphaandcreactiveproteinconcentrationsinpatientswithhereditaryangioedemawithc1inhibitordeficiency